1. Кильдюшевский A.B., Молочков В.А., Карзанов О.В. Динамика клеточного иммунитета в процессе экстракорпоральной фотохимиотерапии у больных истинной пузырчаткой//Рос. журн. кожн. венерич. бол. 2008. N94. С.71-76.

2. Молочков В.А., Кильдюшевский A.B., Молочков A.B. и др. Клинико-иммунологические аспекты экстракорпоральной фотохимиотерапии при псориазе и псориартрическом артрите//Тер. арх. 2012. N910. С.69-74.

3. Федулнина В.А., Ватазин A.B., Кильдюшевсний A.B. и др. Трансляционная клеточная иммунотерапия при аллотрансплантации трупной почки у урологических больных//Альм. клин. мед. 2013. №28. С.25-31.

4. Andreu G., Leon A., Heshmati F. et al. Extracorporeal photochemotherapy (ECP): evaluation of two techniques and use in connective tissues disorders//Transfus. Sei. 1994. V.15. P.443-454.

5. Azuma H., Chandraker A., Nadeau K. et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection//Proc. Nat. Acad. Sei. USA. 1996. V.93. P.12439-12444.

6. Baron E.D., Heeger P.S., Hreecik D.E. et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant Renal allograft rejection//Photodermatol. Photoimmunol. Photomed. 2001. V.17. P.79-82.

7. Barr M.L. et al. Photopheresis for the prevention of rejection in cardiac transplantation//N. Engl. J. Med. 1998. V.339. P.1744-1751.

8. Berger C., Hoffmann K., Vasquez J.G. et al. Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy//Blood. 2010. V.116. P.4838-4847.

9. Berger C.L., Hanlon D., Kanada D. et al. Transimmunization, a novel approach for tumor immunotherapy//Transfus. Apher. Sei. 2002. V.26, No.3. P.205-216.

10. Berthoux F.C., Jones E.H., Mehls О., Valderrabano F. Transplantation Report. 1: renal transplantation in recipients aged 60 years or older at time of grafting. The EDTAERA Registry. European Dialysis and Transplant Association-European Renal Association//Nephrol. Dial. Transplant. 1996. V.ll, Suppl. P.37.

11. Brzezinska A., Magalska A., Szybinska A., Sikora E. Proliferation and apoptosis of human CD8(+)CD28(+) and CD8(+)CD28(-) lymphocytes during aging//Exp. Gerontol. 2004. P.539.

12. Chandraker A., Russell M.E., Glysing-Jensen T. et al. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: Effects of cyclosporine and donor antigen//Transplantation. 1997. V.63. P. 1053-1058.

13. Chang-Qing X., Campbell K.A., Clare-Salzlera M.J. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells//Cur. Opin. Organ Transplant. 2009. V.14, No.4. P.338-343.

14. Christie J.D., Edwards L.B., Kucheryavaya A.Y. et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010//J. Heart Lung Transplant. 2010. V.29, No.10. P.1104-1118.

15. Colombatti A., Doliana R., Schiappacassi M. et al. Age-related persistent clonal expansions of CD28(-) cells: phenotypic and molecular TCR analysis reveals both CD4(+) and CD4(+)CD8(+) cells with identical CDR3 sequences//Clin. Immunol. Immunopathol. 1998. V.89. P.61-68.

16. Crovetti G., Carabelli A., Berti E. et al. Photopheresis in cutaneous T-cell lymphoma: a five-year experience//Int. J. Artif. Organs. 2000. V.23. P.55-62.

17. Dall'Amico R., Murer L. Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection//Transfus. Apher. Sei. 2002. V.26. P.197-204.

18. Di Renzo M., Rubegni P., De Aloe G. et al. Extracorporeal photochemotherapy restores Thl/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma//Immunology. 1997. V.92, No.l. P.99-103.

19. Durrbach A. Advances in immunosuppression for renal transplantation//Nat. Rev. Nephrol, 2010. V.6. P.160-167.

20. Edelson R.L., Berger C.L., Gasparro F.P. et al. Treatment of leukemic cutaneous T-cell lymphoma with extracorporeally photoactivated 8-methoxypsoralen//N. Engl. J. Med. 1987. V.316. P.297-303.

21. Estenne M., Maurer J.R., Boehler A. et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria//J. Heart Lung Transplant. 2002. V.21, No.3. P.297-310.

22. Evans A.V., Wood B.P., Scarisbrick J.J. et al. Extracorporeal photopheresis in Sezary syndrome: hematologic parameters as predictor of response//Blood. 2001. V.98. P.1298-1301.

23. Fenton S., Desmeules M., Copleston P. et al. Renal replacement therapy in Canada: a report from the Canadian Organ Replacement Register//Am. G. Kidney Dis. 1995. V.25. P.134.

24. Ferguson R., Grinyó J., Vincenti F. et al, Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients//Am. J. Transplant. 2011. V.ll, No.l. P.66-76.

25. Fimiani М., Rubegrii Р., Pimpinelli N. et al. Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with mycosis fungoides//Dermatology. 1997, V.194, No.2. P.107-110.

26. Francine M. New insights into the mechanism of action of extracorporeal phototherapy//Transfusion. 2006. V.46. P.6-8.

27. Genberg H., Kumlien G., Shanwell A., Tyden G. Refractory acute renal allograft rejection successfully treated with photopheresis//Transplant. Proc. 2005. V.37. P.3288-3289.

28. Gerber A., Bohne M., Rasch J. et al. Investigation of annexin V binding to lymphocytes after extracorporeal photoimmunotherapy as an early marker of apoptosis//Dermatology. 2000. V.201, No.2. P.lll-117.

29. Girardi M., Berger C.L., Wilson L.D. et al. Transimmunization for cutaneous T cell lymphoma: a Phase I study//Leuk. Lymphoma. 2006. V.47, No.8. P.1495-1503.

30. Heshmati F. Mechanisms of action of extracorporeal photochemotherapy//Transfus. Apher. Sei. 2003. V.29. P.61-70.

31. Hsu H.C., Scott D.K., Zhang P. et al. CD8 T-cell immune phenotype of successful aging//Mech. Ageing Dev. 2006. P.127-231.

32. Jagasia M.H., Savani B.N., Stricklin G. et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)//Biol. Blood Marrow Transplant. 2009. V.15, No.10. P.1288-1295.

33. Kim K.S., Denton M.D., Chandraker A. et al. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: Differential role of B7-1 in initiation versus progression of graft arteriosclerosis//Am. J. Pathol. 2001. V.158. P.977-986.

34. Kirk A.D., Harlan D.M., Armstrong N.N. et al. CTLA4-lg and anti-CD40 ligand prevent renal allograft rejection in primates//Proc. Nat. Acad. Sei. USA. 1997. V.94. P.8789-8794.

35. Knobler R., Barr M.L., Couriel D.R. et al. Extracorporeal photopheresis: past, present, and future//J. Am. Acad. Dermatol. 2009. V.61, No.4. P.652-665.

36. Knobler R., Jantschitsch C. Extracorporeal photo-chemoimmunotherapy in cutaneous T-cell lymphoma//Transfus. Apher. Sei. 2003. V. 28. P.81-89.

37. Treatment of systemic lupus erythematous, a pilot study//Arthrit. Rheum. 1992. V.35. P.319-323.

38. Kumlien G., Genberg H., Shanwell A., Tydén G. Photopheresis for the treatment of refractory renal graft rejection//Transplantation. 2005. V.79, No.l. P.123-125.

39. Kusztal M., Kosmaczewska A., Magott-Procelewska M. et al. CD28 down regulation on CD4+ T cells is associated with age of kidney transplant recipient//Transplantation. 2008. V.21, No.7. P.661-668.

40. Lim H.W., Edelson R.L. Photopheresis for the treatment of cutaneous T-cell Lymphoma//Hematol. Oncol. Clin. North Am. 1995. V.9. P.1117-1124.

41. Maeda A., Beissert S., Schwarz T., Schwarz A. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells//J. Immunol. 2008. V.180, No.5. P.3065-3071.

42. Miller J.D., Kirkland E.B., Domingo D.S. et al. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma//Photodermatol. Photoimmunol. Photomed. 2007. V.23, No.5. P.163-171.

43. Pearson T., Alexander D., Hendrix R. et al. CTLA4-lg plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism//Transplantation. 1995. V.61. P.997-1004.

44. Pearson T.C., Alexander D.Z., Winn K.J. et al. Transplantation tolerance induced by CTLA4-lg//Transplantation. 1994. V.57. P.1701-1706.

45. Peritt D. Potential mechanisms of photopheresis in hematopoietic stem cell transplantation//Biol. Blood Marrow Trans-plant. 2006. V.12. P.7-12.

46. Perseghin P., Dassi M., Balduzzi A. et al. Mononuclear cell collection in patients undergoing extracorporeal photochemotherapy for acute and chronic graft-vs-host disease (GvHD): comparison between СОВЕ Spectra version 4.7 and 6.0 (Auto PBSC)//J. Clin. Apher. 2002. V.17. P.65-71.

47. Perseghin P., Galimberti S., Balduzzi A. et al. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?//Ther. Apher. Dial. 2007. V.U. P.85-93.

48. Rook A.H., Freundlich В., Jegasothy B.V. et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial//Arch. Dermatol. 1992. V.128, No.3. P.337-346.

49. Russell M.E., Hancock W.W., Akalin E. et al. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD 28:B7 costimulation by CTLA4lg modulates T cell and macrophage activation and attenuates arteriosclerosis//J. Clin. Invest. 1996. V.97. P.833-838.

50. Salskov-Iversen M., Berger C.L., Edelson R.L. Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading//J. Im. Bas. Ther. Vac. 2005. V.10. P.1186-1476.

51. Solvaneschi L., Perotti C., Zecca M. et al. Extracorporeal photochemotherapy for the treatment of acute and chronic GVHD in childhood//Transfusion. 2001.V.41. P.1299-1305.

52. Sander-Plassman G., Druml W., Steininger R. et al. Renal allograft rejection controlled by photopheresis//Lancet. 1995. P.346-506.

53. Sayegh M.H., Akalin £, Hancock W.W. et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Thl cytokines but spares Th2//J. Exp. Med. 1995. V.181. P.1869-1874.

54. Scarisbrick J.J., Taylor P., Holtick U. et al. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease//Br. J. Dermatol. 2008. V.158, No.4. P.659-678.

55. Schooneman F. Extracorporeal photopheresis technical aspects//Transfus. Apher. Sei. 2003. V.28. P.51-61.

56. Slovis B.S., Loyd I.Е., King L.E. Photopheresis for chronic rejection of lung allografts//N. Engl. J. Med. 1995. V.332, No.14. P.962-968.

57. Stadler R., Assaf C., Klemke C. et al. S2k Kurzleitlinie Kutane Lymphome. AWMF, 2012.

58. Talpur R., Demierre M.F., Geskin L. et al. Multicenter photopheresis intervention trial in early-stage mycosis fungoides//Clin. Lymph. Myel. Leuk. 2011. V.ll, No.2. P.219-227.

59. Trautinger F., Knobler R., WilIemze R. et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome//Eur. J. Cancer. 2006. V.42, No.8. P.1014-1030.

60. US National Institutes of Health NCI. Mycosis fungoides and the Sezary syndrome treatment (PDQ). Available at: www.nci.nih.gov/cancertopics/pdq/treatment/mycosisfungoides/healthprofessional/all pages.

61. Warrington K.J., Vallejo A.N., Weyand C.M., Goronzy J.L. CD28 loss in senescent CD4+ T cells: reversal by inter-leukin-12 stimulation//Blood. 2003. V.101. P.3543.

1. Kil'dyushevskii A.B., Molochkov V.A., Karzanov O.V. Dinamika kletochnogo immuniteta v protsesse ekstrakorporal'noi fotokhimioterapii u bol'nykh istinnoi puzyrchatkoi//Ros. zhurn. kozhn. venerich. bol. 2008. N94. S.71-76.

2. Molochkov V.A., Kil'dyushevskii A.B., Molochkov A.B. i dr. Kliniko-immunologicheskie aspekty ekstrakorporal'noi fotokhimioterapii pri psoriaze i psoriartricheskom artrite//Ter. arkh. 2012. N910. S.69-74.

3. Fedulnina V.A., Vatazin A.B., Kil'dyushevsnii A.B. i dr. Translyatsionnaya kletochnaya immunoterapiya pri allotransplantatsii trupnoi pochki u urologicheskikh bol'nykh//Al'm. klin. med. 2013. №28. S.25-31.

4. Andreu G., Leon A., Heshmati F. et al. Extracorporeal photochemotherapy (ECP): evaluation of two techniques and use in connective tissues disorders//Transfus. Sei. 1994. V.15. P.443-454.

5. Azuma H., Chandraker A., Nadeau K. et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection//Proc. Nat. Acad. Sei. USA. 1996. V.93. P.12439-12444.

6. Baron E.D., Heeger P.S., Hreecik D.E. et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant Renal allograft rejection//Photodermatol. Photoimmunol. Photomed. 2001. V.17. P.79-82.

7. Barr M.L. et al. Photopheresis for the prevention of rejection in cardiac transplantation//N. Engl. J. Med. 1998. V.339. P.1744-1751.

8. Berger C., Hoffmann K., Vasquez J.G. et al. Rapid generation of maturationally synchronized human dendritic cells: contribution to the clinical efficacy of extracorporeal photochemotherapy//Blood. 2010. V.116. P.4838-4847.

9. Berger C.L., Hanlon D., Kanada D. et al. Transimmunization, a novel approach for tumor immunotherapy//Transfus. Apher. Sei. 2002. V.26, No.3. P.205-216.

10. Berthoux F.C., Jones E.H., Mehls O., Valderrabano F. Transplantation Report. 1: renal transplantation in recipients aged 60 years or older at time of grafting. The EDTAERA Registry. European Dialysis and Transplant Association-European Renal Association//Nephrol. Dial. Transplant. 1996. V.ll, Suppl. P.37.

11. Brzezinska A., Magalska A., Szybinska A., Sikora E. Proliferation and apoptosis of human CD8(+)CD28(+) and CD8(+)CD28(-) lymphocytes during aging//Exp. Gerontol. 2004. P.539.

12. Chandraker A., Russell M.E., Glysing-Jensen T. et al. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: Effects of cyclosporine and donor antigen//Transplantation. 1997. V.63. P. 1053-1058.

13. Chang-Qing X., Campbell K.A., Clare-Salzlera M.J. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells//Cur. Opin. Organ Transplant. 2009. V.14, No.4. P.338-343.

14. Christie J.D., Edwards L.B., Kucheryavaya A.Y. et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010//J. Heart Lung Transplant. 2010. V.29, No.10. P.1104-1118.

15. Colombatti A., Doliana R., Schiappacassi M. et al. Age-related persistent clonal expansions of CD28(-) cells: phenotypic and molecular TCR analysis reveals both CD4(+) and CD4(+)CD8(+) cells with identical CDR3 sequences//Clin. Immunol. Immunopathol. 1998. V.89. P.61-68.

16. Crovetti G., Carabelli A., Berti E. et al. Photopheresis in cutaneous T-cell lymphoma: a five-year experience//Int. J. Artif. Organs. 2000. V.23. P.55-62.

17. Dall'Amico R., Murer L. Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection//Transfus. Apher. Sei. 2002. V.26. P.197-204.

18. Di Renzo M., Rubegni P., De Aloe G. et al. Extracorporeal photochemotherapy restores Thl/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma//Immunology. 1997. V.92, No.l. P.99-103.

19. Durrbach A. Advances in immunosuppression for renal transplantation//Nat. Rev. Nephrol, 2010. V.6. P.160-167.

20. Edelson R.L., Berger C.L., Gasparro F.P. et al. Treatment of leukemic cutaneous T-cell lymphoma with extracorporeally photoactivated 8-methoxypsoralen//N. Engl. J. Med. 1987. V.316. P.297-303.

21. Estenne M., Maurer J.R., Boehler A. et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria//J. Heart Lung Transplant. 2002. V.21, No.3. P.297-310.

22. Evans A.V., Wood B.P., Scarisbrick J.J. et al. Extracorporeal photopheresis in Sezary syndrome: hematologic parameters as predictor of response//Blood. 2001. V.98. P.1298-1301.

23. Fenton S., Desmeules M., Copleston P. et al. Renal replacement therapy in Canada: a report from the Canadian Organ Replacement Register//Am. G. Kidney Dis. 1995. V.25. P.134.

24. Ferguson R., Grinyó J., Vincenti F. et al, Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients//Am. J. Transplant. 2011. V.ll, No.l. P.66-76.

25. Fimiani M., Rubegrii R., Pimpinelli N. et al. Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with mycosis fungoides//Dermatology. 1997, V.194, No.2. P.107-110.

26. Francine M. New insights into the mechanism of action of extracorporeal phototherapy//Transfusion. 2006. V.46. P.6-8.

27. Genberg H., Kumlien G., Shanwell A., Tyden G. Refractory acute renal allograft rejection successfully treated with photopheresis//Transplant. Proc. 2005. V.37. P.3288-3289.

28. Gerber A., Bohne M., Rasch J. et al. Investigation of annexin V binding to lymphocytes after extracorporeal photoimmunotherapy as an early marker of apoptosis//Dermatology. 2000. V.201, No.2. P.lll-117.

29. Girardi M., Berger C.L., Wilson L.D. et al. Transimmunization for cutaneous T cell lymphoma: a Phase I study//Leuk. Lymphoma. 2006. V.47, No.8. P.1495-1503.

30. Heshmati F. Mechanisms of action of extracorporeal photochemotherapy//Transfus. Apher. Sei. 2003. V.29. P.61-70.

31. Hsu H.C., Scott D.K., Zhang P. et al. CD8 T-cell immune phenotype of successful aging//Mech. Ageing Dev. 2006. P.127-231.

32. Jagasia M.H., Savani B.N., Stricklin G. et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)//Biol. Blood Marrow Transplant. 2009. V.15, No.10. P.1288-1295.

33. Kim K.S., Denton M.D., Chandraker A. et al. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: Differential role of B7-1 in initiation versus progression of graft arteriosclerosis//Am. J. Pathol. 2001. V.158. P.977-986.

34. Kirk A.D., Harlan D.M., Armstrong N.N. et al. CTLA4-lg and anti-CD40 ligand prevent renal allograft rejection in primates//Proc. Nat. Acad. Sei. USA. 1997. V.94. P.8789-8794.

35. Knobler R., Barr M.L., Couriel D.R. et al. Extracorporeal photopheresis: past, present, and future//J. Am. Acad. Dermatol. 2009. V.61, No.4. P.652-665.

36. Knobler R., Jantschitsch C. Extracorporeal photo-chemoimmunotherapy in cutaneous T-cell lymphoma//Transfus. Apher. Sei. 2003. V. 28. P.81-89.

37. Treatment of systemic lupus erythematous, a pilot study//Arthrit. Rheum. 1992. V.35. P.319-323.

38. Kumlien G., Genberg H., Shanwell A., Tydén G. Photopheresis for the treatment of refractory renal graft rejection//Transplantation. 2005. V.79, No.l. P.123-125.

39. Kusztal M., Kosmaczewska A., Magott-Procelewska M. et al. CD28 down regulation on CD4+ T cells is associated with age of kidney transplant recipient//Transplantation. 2008. V.21, No.7. P.661-668.

40. Lim H.W., Edelson R.L. Photopheresis for the treatment of cutaneous T-cell Lymphoma//Hematol. Oncol. Clin. North Am. 1995. V.9. P.1117-1124.

41. Maeda A., Beissert S., Schwarz T., Schwarz A. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells//J. Immunol. 2008. V.180, No.5. P.3065-3071.

42. Miller J.D., Kirkland E.B., Domingo D.S. et al. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma//Photodermatol. Photoimmunol. Photomed. 2007. V.23, No.5. P.163-171.

43. Pearson T., Alexander D., Hendrix R. et al. CTLA4-lg plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism//Transplantation. 1995. V.61. P.997-1004.

44. Pearson T.C., Alexander D.Z., Winn K.J. et al. Transplantation tolerance induced by CTLA4-lg//Transplantation. 1994. V.57. P.1701-1706.

45. Peritt D. Potential mechanisms of photopheresis in hematopoietic stem cell transplantation//Biol. Blood Marrow Trans-plant. 2006. V.12. P.7-12.

46. Perseghin P., Dassi M., Balduzzi A. et al. Mononuclear cell collection in patients undergoing extracorporeal photochemotherapy for acute and chronic graft-vs-host disease (GvHD): comparison between SOVE Spectra version 4.7 and 6.0 (Auto PBSC)//J. Clin. Apher. 2002. V.17. P.65-71.

47. Perseghin P., Galimberti S., Balduzzi A. et al. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?//Ther. Apher. Dial. 2007. V.U. P.85-93.

48. Rook A.H., Freundlich V., Jegasothy B.V. et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial//Arch. Dermatol. 1992. V.128, No.3. P.337-346.

49. Russell M.E., Hancock W.W., Akalin E. et al. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD 28:B7 costimulation by CTLA4lg modulates T cell and macrophage activation and attenuates arteriosclerosis//J. Clin. Invest. 1996. V.97. P.833-838.

50. Salskov-Iversen M., Berger C.L., Edelson R.L. Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading//J. Im. Bas. Ther. Vac. 2005. V.10. P.1186-1476.

51. Solvaneschi L., Perotti C., Zecca M. et al. Extracorporeal photochemotherapy for the treatment of acute and chronic GVHD in childhood//Transfusion. 2001.V.41. P.1299-1305.

52. Sander-Plassman G., Druml W., Steininger R. et al. Renal allograft rejection controlled by photopheresis//Lancet. 1995. P.346-506.

53. Sayegh M.H., Akalin £, Hancock W.W. et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Thl cytokines but spares Th2//J. Exp. Med. 1995. V.181. P.1869-1874.

54. Scarisbrick J.J., Taylor P., Holtick U. et al. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease//Br. J. Dermatol. 2008. V.158, No.4. P.659-678.

55. Schooneman F. Extracorporeal photopheresis technical aspects//Transfus. Apher. Sei. 2003. V.28. P.51-61.

56. Slovis B.S., Loyd I.E., King L.E. Photopheresis for chronic rejection of lung allografts//N. Engl. J. Med. 1995. V.332, No.14. P.962-968.

57. Stadler R., Assaf C., Klemke C. et al. S2k Kurzleitlinie Kutane Lymphome. AWMF, 2012.

58. Talpur R., Demierre M.F., Geskin L. et al. Multicenter photopheresis intervention trial in early-stage mycosis fungoides//Clin. Lymph. Myel. Leuk. 2011. V.ll, No.2. P.219-227.

59. Trautinger F., Knobler R., WilIemze R. et al. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome//Eur. J. Cancer. 2006. V.42, No.8. P.1014-1030.

60. US National Institutes of Health NCI. Mycosis fungoides and the Sezary syndrome treatment (PDQ). Available at: www.nci.nih.gov/cancertopics/pdq/treatment/mycosisfungoides/healthprofessional/all pages.

61. Warrington K.J., Vallejo A.N., Weyand C.M., Goronzy J.L. CD28 loss in senescent CD4+ T cells: reversal by inter-leukin-12 stimulation//Blood. 2003. V.101. P.3543.